4.5 Editorial Material

Retained placenta: will medical treatment ever be possible?

期刊

出版社

WILEY
DOI: 10.1111/aogs.12848

关键词

Retained placenta; medical treatment; way through medical treatment; delivery; postpartum hemorrhage

资金

  1. National Institute for Health Research [II-LA-0712-20007] Funding Source: researchfish
  2. Department of Health [II-LA-0715-20008, II-LA-0712-20007] Funding Source: Medline
  3. National Institutes of Health Research (NIHR) [II-LA-0712-20007] Funding Source: National Institutes of Health Research (NIHR)

向作者/读者索取更多资源

The standard treatment for retained placenta is manual removal whatever its subtype (adherens, trapped or partial accreta). Although medical treatment should reduce the risk of anesthetic and surgical complications, they have not been found to be effective. This may be due to the contrasting uterotonic needs of the different underlying pathologies. In placenta adherens, oxytocics have been used to contract the retro-placental myometrium. However, if injected locally through the umbilical vein, they bypass the myometrium and perfuse directly into the venous system. Intravenous injection is an alternative but exacerbates a trapped placenta. Conversely, for trapped placentas, a relaxant could help by resolving cervical constriction, but would worsen the situation for placenta adherens. This confusion over medical treatment will continue unless we can find a way to diagnose the underlying pathology. This will allow us to stop treating the retained placenta as a single entity and to deliver targeted treatments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据